Clinical use of nebivolol in the treatment of chronic heart failure

Hellenic Journal of Cardiology

Volumn 46, Issue 3, 2005, Pages 208-211

  Liberopoulos, Evagelos N ^a   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Betablockers; Dilated cardiomyopathy; Heart failure; Nebivolol; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL; NEBIVOLOL; BENZOPYRAN DERIVATIVE; ETHANOLAMINE DERIVATIVE;

CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; EXERCISE; HEART FAILURE; HEART RATE; HEMODYNAMICS; HUMAN; NOTE; SYSTOLIC BLOOD PRESSURE; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; BENZOPYRANS; ETHANOLAMINES; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 24644450314     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Note

References (28)

1. Haldeman GA, Croft JB, Giles WH, Rashidee A: Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137: 352-360.
2. Yan AT, Yan RT, Liu PP: Narrative review: Pharmacotherapy of chronic heart failure: Evidence from recent clinical trials. Ann Intern Med 2005; 142: 132-145.
3. Remme WJ, Swedberg K: Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Eur J Heart Fail 2002; 4: 11-22.
4. Hunt SA, Baker DW, Chin MH, et al: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2001. Accessed at www.acc.org/clinical/guidelines/failure/hf_index. htm.
5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
6. Packer M, Bristow MR, Cohn JN, et al: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-1355.
7. Packer M, Coats AJ, Fowler MB, et al: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
8. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HP). Lancet 1999; 353: 2001-2007.
9. Satwani S, Dec GW, Narula J: β-Adrenergic blockers in heart failure: Review of mechanisms of action and clinical outcomes. J Cardiovasc Pharmacol Ther 2004; 9: 243-255.
10. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001; 344: 1659-1667.
11. Poole-Wilson PA, Swedberg K, Cleland JG, et al: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003; 362: 7-13.
12. Cockcroft J: Nebivolol: A review. Expert Opin Pharmacother 2004; 5: 893-899.
13. Zanchetti A: Clinical pharmacodynamics of nebivolol: New evidence of nitric-oxide mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients. Blood Press Suppl 2004; 1: 17-32.
14. Kuroedov A, Cosentino F, Luscher TF: Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol. Cardiovasc Drug Rev 2004; 22: 155-168.
15. Rizos E, Bairaktari E, Kostoula A, et al: The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidaemia: A pilot study. J Cardiovasc Pharmacol Ther 2003; 8: 127-134.
16. Wisenbaugh T, Katz I, Davis J, et al: Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 1993; 21: 1094-1100.
17. Uhlir O, Dvorak I, Gregor P, et al: Nebivolol in the treatment of cardiac failure: A double-blind controlled clinical trial. J Card Fail 1997; 3: 271-276.
18. Brehm BR, Wolf SC, Gorner S, Buck-Muller N, Risler T: Effect of nebivolol on left ventricular function in patients with chronic heart failure: A pilot study. Eur J Heart Fail 2002; 4: 757-763.
19. Nodari S, Metra M, Dei Cas L: Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized comparison of the long-term effects of atenolol vs. nebivolol. Eur J Heart Fail 2003; 5: 621-627.
20. Patrianakos AP, Parthenakis FI, Mavrakis HE, et al: Effects of nebivolol on left ventricular function and exercise capacity in patients with non-ischemic dilated cardiomyopathy. A randomised placebo-controlled study. Hell J Cardiol 2005; 46: 199-207.
21. Waagstein F, Stromblad O, Andersson B, et al: Increased exercise ejection fraction and reversed remodelling after long-term treatment with metoprolol in congestive heart failure: A randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy. Eur J Heart Fail 2003; 5: 679-691.
22. Tousoulis D, Charakida M, Stefanadis C: Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure. Int J Cardiol 2005; 100: 347-353.
23. Katz SD, Hryniewicz K, Hriljac I, et al: Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005; 111: 310-314.
24. Flather M, Shibata M, Coats A, et al: Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-225.
25. McMurray J: Making sense of SENIORS. Eur Heart J 2005; 26: 203-206.
26. Komajda M, Follath F, Swedberg K, et al: Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003; 24: 464-474.
27. Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP: Early statin therapy in patients with acute coronary syndrome. Hell J Cardiol 2005; 46: 5-8.
28. Ventura HO: Benefits of inpatients initiation of β-blockers. Am Heart J 2004; 148: 944-950.